Log in
Enquire now
‌

US Patent 9198869 Manufacture of peanut formulations for oral desensitization

Patent 9198869 was granted and assigned to Aimmune Therapeutics on December, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Aimmune Therapeutics
Aimmune Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9198869
Date of Patent
December 1, 2015
Patent Application Number
14207165
Date Filed
March 12, 2014
Patent Citations Received
‌
US Patent 12090178 Methods for making mixed allergen compositions
0
‌
US Patent 11766477 Methods for making mixed allergen compositions
‌
US Patent 12016917 Peanut formulations and uses thereof
0
Patent Primary Examiner
‌
Robert A Wax
Patent abstract

The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9198869 Manufacture of peanut formulations for oral desensitization

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.